APA (7th ed.) Citation

P, A., S, F., AA, A., D, B., DL, H., M, L., . . . EML, S. (2026). Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): Consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice-a narrative review. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 34(6), . https://doi.org/10.1007/s00520-026-10690-2

Chicago Style (17th ed.) Citation

P, Alberti, et al. "Serum Neurofilament Light Chain (sNFL) as a Predictive Biomarker for Chemotherapy-induced Peripheral Neurotoxicity (CIPN): Consideration of Current Evidence, Validation Steps, and Barriers to CIPN Biomarker Implementation in Clinical Practice-a Narrative Review." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 34, no. 6 (2026). https://doi.org/10.1007/s00520-026-10690-2.

MLA (9th ed.) Citation

P, Alberti, et al. "Serum Neurofilament Light Chain (sNFL) as a Predictive Biomarker for Chemotherapy-induced Peripheral Neurotoxicity (CIPN): Consideration of Current Evidence, Validation Steps, and Barriers to CIPN Biomarker Implementation in Clinical Practice-a Narrative Review." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 34, no. 6, 2026, https://doi.org/10.1007/s00520-026-10690-2.